| Page | |||
|---|---|---|---|
| Report ofthe Trustees | I | to | 4 |
| Report ofthe Independent Auditors |
5 | to | 8 |
| Statement ofFinancial Activities | |||
| Balance Sheet | 10 | ||
| Notes to the Financial Statements | 11 | to | 17 |
| Detailed Statement ofFinancial Activities | 18 | to | 19 |
| 30.9.21 | 30.9.20 | ||||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||||
| fund | fund | funds | funds | ||||
| Notes | |||||||
| INCOME AND ENDOWMENTS FROM | |||||||
| Donations and legacies |
19,557 | 27,946 | 47,503 | 18,884 | |||
| Charitable activities |
|||||||
| Research into and education | on oncology | 28,528 | 28,528 | 37,584 | |||
| Investment income |
2 | 9,179 | 36,771 | 45,950 | 40,188 | ||
| Other income | 1300 | 1380 | 140D | ||||
| Total | 28,736 | 94,625 | 123,361 | 98,056 | |||
| EXPENDITURE ON | |||||||
| Raising funds | 3 | 3,600 | 14,452 | 18,052 | 13,339 | ||
| Charitable activities |
|||||||
| Research into and education | on oncology | 12,411 | 54,497 | 66,908 | 82,412 | ||
| Total | 16,011 | 68,949 | 84,960 | 95,751 | |||
| Net gains/(losses) on |
investments | ~25969 | 1D4,251 | 130226 | ~120062 | ||
| NET INCOME/(EXPENDITURE) | 38,694 | 129,933 | 168,627 | (116,557) | |||
| RECONCILIATION | OF FUNDS | ||||||
| Total funds brought | forward | 279,437 | 1,121,867 | 1,401,304 | 1,517,861 | ||
| TOTAL FUNDS CARRIED FORWARD | 310,131 | 1251 800 | 1569,931 | I 401 3D4 |
| 30.9.21 | 30.9.20 | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||
| Notes | fund f |
fund | funds | funds | |
| FIXEDASSETS | |||||
| Investments | 11 | 175,566 | 1,093,704 | 1,269,270 | 1,112,186 |
| CURRENT ASSETS | |||||
| Debtors Cash at bank |
12 | 2,593 ~150352 |
17,534 161,698 |
20,127 ~312050 |
15,985 284,280 |
| 152,945 | 179,232 | 332,177 | 300,265 | ||
| CREDITORS | |||||
| Amounts falling due within one year |
13 | (10,380) | (21,136) | (31,516) | (11,147) |
| NET CURRENT ASSETS | 142,565 | 158,096 | 300,661 | 289,118 | |
| TOTAL ASSETSLESSCURRENT | |||||
| LIABILITIES | 318,131 | 1,251,800 | 1,569,931 | 1,401,304 | |
| NET ASSETS | ~325 131 | 1 251,SDD | 1569 932 | 1,401,304 | |
| FUNDS | 14 | ||||
| Unrestricted funds Restricted funds |
318,131 1,251,800 |
279,437 1,121,867 |
|||
| TOTAL FUNDS | 1,569,931 | 1,401,304 |
| Short term trade creditors | are measured | at the transaction | at the transaction | price. Other financial | liabilities, including |
liabilities, including |
bank loans, |
|---|---|---|---|---|---|---|---|
| are measured initially at |
fair value, net | of transaction | costs, and are measured | subsequently | at amortised cost |
||
| using the effective interest | method. | ||||||
| INVESTMENT INCOME | |||||||
| 30.9.21 f |
30.9.20 f |
||||||
| Other investment income |
45,914 | 39,774 | |||||
| Deposit account interest | 36 | 414 | |||||
| 45,950 | 40,188 | ||||||
| RAISING FUNDS | |||||||
| Investment management |
costs | ||||||
| 30.9.21 f |
30.9.20 f |
||||||
| Portfolio management | 18,052 | 13,339 |
| Governance | |||||||
|---|---|---|---|---|---|---|---|
| Other | costs | Totals | |||||
| f | f | ||||||
| Research | into and education | on oncology | ~9246 | ~4800 | 14,046 | ||
| NET INCOME/(EXPENDITURE) | |||||||
| Net income/(expenditure) | is | stated atter charging/(crediting): | |||||
| 30.9.21 | 30.9.20 | ||||||
| Auditors' | remuneration | 3,600 | 3,600 | ||||
| Auditors' | remuneration | for non-audit | work | ~1200 | 1,200 |
| 30.9.21 | 30.9.20 | |||
|---|---|---|---|---|
| f | ||||
| Wages | and | salaries | 45,667 | 54,459 |
| 45,667 | 54,459 |
| Staffcosts are solely | made up ofwages recharged | made up ofwages recharged | t'rom various | trusts during the year. | |
|---|---|---|---|---|---|
| The average monthly | number ofemployees | during | the year was | as follows: | |
| Research staff | 30.9.21 2 |
30.9.20 =2 |
| During the year an ex-grati for the work undertaken in |
a payment ofI3,000 was made to the volunteer bookke managing the charities accounting function. |
a payment ofI3,000 was made to the volunteer bookke managing the charities accounting function. |
eper for the c | harity as thanks |
|---|---|---|---|---|
| COMPARATIVES FOR | THE STATEMENT OFFINANCIAL ACTIVITIES | |||
| Unrestricted | Restricted | Total | ||
| fund | fund | funds | ||
| 8 | ||||
| INCOME AND ENDOWMENTS FROM | ||||
| Donations and legacies |
7,529 | 11,355 | 18,884 | |
| Charitable activities |
||||
| Research into and education | on oncology | 37,584 | 37,584 | |
| investment income |
8,064 | 32,124 | 40,188 | |
| Other income | 1,400 | 1,400 | ||
| Total | 15,593 | 82,463 | 98,056 | |
| EXPENDITURE ON | ||||
| Raising funds | 2,658 | 10,681 | 13,339 | |
| Charitable activities |
||||
| Research into and education | on oncology | 12,273 | 70,139 | 82,412 |
| Total | 14,931 | 80,820 | 95,751 | |
| Net gains/(losses) on investments |
~23,686 | ~96.)36) | ~))8,862) | |
| NET INCOME/(EXPENDITURE) | (23,024) | (93,533) | (116,557) | |
| RECONCILIATION OFFUNDS |
||||
| Total funds brought forward | 302,461 | 1,215,400 | 1,517,861 | |
| TOTAL FUNDS CARRIED FORWARD | 279,437 | 1,121,867 | 1 401,304 |
| Listed | ||
|---|---|---|
| investments | ||
| MARKET VALUE | ||
| At 1 October 2020 | 1,112,186 | |
| Additions | 508,074 | |
| Disposals | (450384) | |
| Revaluations | 99,394 | |
| At 30September 2021 | 1,269,270 | |
| NET BOOK VALUE | ||
| At 30September 2021 | 1,269,270 | |
| At 30 September 2020 | 1,112,186 | |
| There were no investment | assets outside the UK. |
| Listed | ||||
|---|---|---|---|---|
| investments | ||||
| Valuation | in | 2021 | 99,394 | |
| Cost | 1169976 | |||
| 1269276 | ||||
| DEBTORS: | AMOUNTS FALLING DUK WITHIN ONE YEAR | |||
| 30.9.21 | 30.9.20 | |||
| g | I | |||
| Other debtors | 13,192 | 3,153 | ||
| Prepayments | and accrued income | ~6935 | 12,832 | |
| 20,127 | 15,985 |
| 13. | CREDITORS: | CREDITORS: | AMOUNTS FALLING DUE WITHIN ONE YEAR | AMOUNTS FALLING DUE WITHIN ONE YEAR | AMOUNTS FALLING DUE WITHIN ONE YEAR | AMOUNTS FALLING DUE WITHIN ONE YEAR | AMOUNTS FALLING DUE WITHIN ONE YEAR | AMOUNTS FALLING DUE WITHIN ONE YEAR | AMOUNTS FALLING DUE WITHIN ONE YEAR | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.9.21 | 30.9.20 | |||||||||||||||
| f | ||||||||||||||||
| Trade creditors | 23,716 | 410 | ||||||||||||||
| Accrued expenses | ~7000 | ~10 737 | ||||||||||||||
| 31,516 | 11,147 | |||||||||||||||
| 14. | MOVEMENT | IN FUNDS | ||||||||||||||
| The restricted | funds below, are funds | held by the Trust on behalf ofConsultants | and applied | for | their research | |||||||||||
| projects. When | funds | are received | for a specific consultant, | they are | allocated | the | relevant | Consultants fund |
||||||||
| under Restricted | Funds. Any other | funds, non-specific, are allocated |
to the | General | fund, | under | Unrestricted | |||||||||
| Funds. | ||||||||||||||||
| The Development | fund | is a grant based fund to cover general | administration | expenses | and | staff | development. | |||||||||
| Cyberknife and |
Head | and Neck Funds are restricted |
for specific treatments | and | can | be used by named fund |
||||||||||
| holders. | ||||||||||||||||
| At | incondng | Resources | Gains | Trsnslers | ||||||||||||
| 01.10.20 f |
Resources | expended f |
nnd losses 5 |
betweea fundsf |
At 30.09.21 5 |
|||||||||||
| Unrestricted funds |
||||||||||||||||
| General Breast |
118,794 46,516 |
16,454 1,524 |
(13471) (1,249) |
11,040 4,323 |
133,017 51,114 |
|||||||||||
| Development Fightiug Breast |
85,979 | 2,817 | (1,108) | 7,990 | 95,678 | |||||||||||
| Cancer | 28,148 | 7 41 | 383 | 2,616 | 38,322 | |||||||||||
| 279,437 | 28,736 | (16,011) | 25,969 | 318,131 | ||||||||||||
| Restricted funds | ||||||||||||||||
| FrofP Hoskin Dr AMskris Dr P Ostler Dr C Lemon/ Dr K |
527417 91,454 25,287 |
55,650 2,997 829 |
(44,728) (2,259) (326) |
48,995 8,499 2,350 |
587,134 100,69i 28,140 |
|||||||||||
| Chiu Dr M Harrison Dr N Shah Dr D Miles Dr SMewdsley Dr RAlonzi Development Cyberkoife Fund Dr Westbuiy |
176/68 18,540 65,279 96,678 13,665 20,550 68,170 8,944 |
22,875 607 2,139 3,418 448 1,051 2/34 515 |
(15Z58) (239) (841) (3,473) (176) (298) (878) (351) |
16,409 1,723 6,067 8/84 t/70 tg10 6,335 831 |
200,594 20,631 72,644 105,607 15,207 23,213 75,861 9s)39 |
|||||||||||
| /Guppy Dr Neel Bhuvs Brschy |
6,071 3,444 |
199 2463 300 |
(78) (44) |
564 320 |
6,756 5,083 300 |
|||||||||||
| ~1121,867 | 94,625 | ~68,949) | ~104257 | tZ51,800 |
| TOTAL | FUNDS | |||||||
|---|---|---|---|---|---|---|---|---|
| ~1401304 | 123361 | ~04 | 960) | ~130226 | - | ~1569Tt31 |
| Detailed Statement ofFinancial Activities | Detailed Statement ofFinancial Activities | ||
|---|---|---|---|
| for the Year Ended 30Se | tember 2021 | ||
| 30.9.21 | 30.9.20 | ||
| INCOME AND ENDOWMENTS | |||
| Donations and legacies |
|||
| Donations | 30,180 | 17,884 | |
| Legacies | ~17 323 | 1 000 | |
| 47,503 | 18,884 | ||
| Investment income |
|||
| Other investment income |
45,914 | 39,774 | |
| Deposit account interest | 36 | 414 | |
| 45,950 | 40,188 | ||
| Charitable activities |
|||
| Grants | 28,528 | 37,584 | |
| Other income | |||
| Training income |
1,080 | 1,400 | |
| Other income | 300 | ||
| 1 80 |
1,400 | ||
| Total incoming resources | 123,361 | 98,056 | |
| EXPENDITURE | |||
| Investment management |
costs | ||
| Portfolio management | 18,052 | 13,339 | |
| Charitable activities |
|||
| Research salaries | 45,667 | 54,459 | |
| Research materials | 4,919 | 1,705 | |
| Transport expenses |
90 | ||
| Lecture fees | (110) | ||
| Conference | 1,996 | 6,527 | |
| Computer expenses |
280 | 4,412 | |
| 52,862 | 67,083 | ||
| Support costs | |||
| Other | |||
| Subscriptions | 1,432 | 1,526 | |
| Administrative expenses |
7,576 | 8,288 | |
| Travelling | 238 | 715 | |
| 9,246 | 10,529 |
| for the Year Ended 30 S | e tember 202 | 1 | ||
|---|---|---|---|---|
| 30.9.21 | 30.9.20 | |||
| Other | ||||
| Governance costs |
||||
| Auditors' remuneration Auditors' remuneration |
for non-audit | work | 3,600 ~1200 |
3,600 1200 |
| ~4800 | 4,800 | |||
| Total resources expended | ~84 960 | 95,751 | ||
| Net income before gains | and losses | 38,401 | 2,305 | |
| Realised recognised gains and losses |
||||
| Realised gains/(losses) on fixed asset |
investments | 24,858 | f28,659) | |
| Net income/(expenditure) | 63,259 | ~26,354) |